Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan Dual and Triple Therapy for H. Pylori
NCT07045688Recruiting
- Sponsor
- Sohag University
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by Sohag University. Primary endpoint: Efficacy medical treatment for eradication of Helicobacter Pylori infection. Started May 2025; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07045688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045688.